CD274 and neoplasm: There was no significant correlation between PD-L1 immunoreactivity and clinical outcome; Kaplan–Meier analysis showed that patients with PD-L1-positive tumors had shorter OS, but the difference was nonsignificant and most likely explained by the association to high tumor grade (Figure 3).